NCT05881681

Brief Summary

The goal of this clinical trial is to test an app-based mindfulness training program in an Afro-descendant population. The main question\[s\] it aims to answer are:

  • What changes, if any, does the app need?
  • Is it effective in reducing anxiety among this population? Participants will be asked to:
  • Use an app-based mindfulness training program daily
  • Complete online surveys at baseline and 2 months post-treatment initiation
  • Complete focused interviews via Zoom at baseline and 2 months post-treatment initiation
  • Complete daily voice diaries via Zoom

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 31, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

1.4 years

First QC Date

November 4, 2022

Last Update Submit

March 13, 2024

Conditions

Keywords

Worry

Outcome Measures

Primary Outcomes (2)

  • Focused interviews

    In-depth interviews will be conducted to collect participant feedback.

    Baseline

  • Focused interviews

    In-depth interviews will be conducted to collect participant feedback.

    2 months

Secondary Outcomes (3)

  • Change in anxiety

    Baseline, 2 months

  • Change in worry

    Baseline, 2 months

  • Change in non-reactivity

    Baseline, 2 months

Study Arms (1)

App-Delivered Mindfulness Training (MT)

EXPERIMENTAL

The Unwinding Anxiety program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment.

Behavioral: App-Delivered Mindfulness Training (MT)

Interventions

Unwinding Anxiety is an app-delivered mindfulness training program which includes a progression through 30+ daily modules. Each module's training is delivered via short video tutorials and animations (\~10 min/day). Each training builds on the previous one; modules are 'locked' so that they can only be viewed at a pace of 1/day (previous modules can be reviewed at any time). A built-in self-assessment is taken after every seven modules to ensure key concepts are learned before moving on with automated suggestions on which modules to repeat based on the self-assessment results. User-initiated guided practices range from short exercises (30 seconds) to manage anxiety the moment it arises to formal guided meditations (up to 15 minutes), and can be accessed at any time

App-Delivered Mindfulness Training (MT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • GAD-7 ≥ 10
  • Self-identify as Black American and/or Afro-descendant
  • Located in United States or Canada
  • Able to speak English
  • Owns a smartphone

You may not qualify if:

  • Any usage of psychotropic medication: not on a stable dosage 6+ weeks
  • As needed (i.e., prn) benzodiazepine use
  • Psychotic disorder (e.g., bipolar disorder, schizophrenia, schizoaffective disorder, psychosis)
  • Cohabiting with a study participant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15215, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Judson A Brewer

    Brown University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2022

First Posted

May 31, 2023

Study Start

September 6, 2022

Primary Completion

February 5, 2024

Study Completion

February 5, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations